NO20064463L - Opioid leveringssystem - Google Patents
Opioid leveringssystemInfo
- Publication number
- NO20064463L NO20064463L NO20064463A NO20064463A NO20064463L NO 20064463 L NO20064463 L NO 20064463L NO 20064463 A NO20064463 A NO 20064463A NO 20064463 A NO20064463 A NO 20064463A NO 20064463 L NO20064463 L NO 20064463L
- Authority
- NO
- Norway
- Prior art keywords
- formulation
- opioid
- delivery
- drug
- pulmonary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45033303P | 2003-02-28 | 2003-02-28 | |
US10/788,466 US7648981B2 (en) | 2003-02-28 | 2004-03-01 | Opioid delivery system |
PCT/CA2004/000303 WO2004075879A1 (en) | 2003-02-28 | 2004-03-01 | Opioid delivery system |
PCT/CA2004/001578 WO2005082369A1 (en) | 2003-02-28 | 2004-08-27 | Opioid delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064463L true NO20064463L (no) | 2006-11-30 |
Family
ID=42354335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064463A NO20064463L (no) | 2003-02-28 | 2006-10-02 | Opioid leveringssystem |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1732555A4 (de) |
KR (1) | KR20070011344A (de) |
CN (1) | CN1938027A (de) |
AU (1) | AU2004316339A1 (de) |
NO (1) | NO20064463L (de) |
WO (1) | WO2005082369A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2029197A2 (de) * | 2006-06-21 | 2009-03-04 | Universität Bern | System zur kontrolle der verabreichung von anästhesie |
KR20220126409A (ko) | 2021-03-09 | 2022-09-16 | 주식회사 퍼넥티브 | 비대면 영어 교육 플랫폼 및 외국어 학습방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8900267D0 (en) * | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
US5451408A (en) * | 1994-03-23 | 1995-09-19 | Liposome Pain Management, Ltd. | Pain management with liposome-encapsulated analgesic drugs |
JP3911290B2 (ja) * | 1994-05-13 | 2007-05-09 | アラダイム コーポレーション | エアゾールを含む麻酔用処方 |
GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
EP1392262A1 (de) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Verabreichung von arzneimittel-estern durch inhalation |
US20030051728A1 (en) * | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
-
2004
- 2004-08-27 WO PCT/CA2004/001578 patent/WO2005082369A1/en active Application Filing
- 2004-08-27 EP EP04761742A patent/EP1732555A4/de not_active Withdrawn
- 2004-08-27 AU AU2004316339A patent/AU2004316339A1/en not_active Abandoned
- 2004-08-27 KR KR1020067020229A patent/KR20070011344A/ko not_active Application Discontinuation
- 2004-08-27 CN CNA2004800426691A patent/CN1938027A/zh active Pending
-
2006
- 2006-10-02 NO NO20064463A patent/NO20064463L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1732555A4 (de) | 2008-07-16 |
AU2004316339A1 (en) | 2005-09-09 |
WO2005082369A1 (en) | 2005-09-09 |
CN1938027A (zh) | 2007-03-28 |
KR20070011344A (ko) | 2007-01-24 |
EP1732555A1 (de) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007470A (es) | Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2. | |
WO2006023989A3 (en) | Gas delivery and monitoring system | |
MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
WO2006016953A3 (en) | Bis closed loop anesthetic delivery | |
NO20052420L (no) | Farmakologisk behandling av sovnapn±. | |
WO2007033050A3 (en) | Synchronization of repetitive therapeutic interventions | |
ATE339954T1 (de) | Kombinationen von formoterol und tiotropium-salz | |
PL363042A1 (en) | Air in-line sensor for ambulatory drug infusion pump | |
WO2005061046A3 (en) | Method and apparatus for modifying delivery of a therapy in response to onset of sleep | |
IL208184A0 (en) | Glp-1, and methods for treating diabetes | |
NO20071505L (no) | Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger. | |
WO2005044331A3 (en) | Method and system of sensing a patient’s airflow | |
DK1458388T3 (da) | En flydende farmaceutisk formulering omfattende nikotin til administrering i mundhulen | |
NO20065878L (no) | Terapeutiske forbindelser | |
NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
NO20064964L (no) | Behandling av svekket respiratorisk funksjon | |
GEP20084567B (en) | Carbostyril derivatives and mood stabilizers for treating mood disorders | |
CY1119580T1 (el) | Νεα φαρμακα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας | |
IL176758A0 (en) | 1,3-dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes | |
NZ590839A (en) | Treatment of pulmonary arterial hypertension | |
WO2006045314A3 (en) | Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease | |
NO20064463L (no) | Opioid leveringssystem | |
AU2003252182A8 (en) | Therapeutic treatment for the metabolic syndrome and type 2 diabetes | |
CY1109215T1 (el) | Συστημα χορηγησης οπιοειδους | |
IS8373A (is) | Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |